Until recently, there has been little data available on how much effort football players exert in games versus practices, which position groups run the most or how to balance loads in practice to best meet […]
With a simple standard MRI scan of the brain, it may soon be possible to predict which people with mental illnesses will gain weight after their initial diagnosis—thereby increasing their risk of physical diseases—and which […]
Research from the University of Gothenburg, Sweden, clarifies the complex interaction between gut bacteria and irritable bowel syndrome (IBS). Experiments demonstrate that gut bacteria can produce the important substance serotonin. The finding may lead to […]
There are currently no available treatment options for more than 90% of the approximately 7,000 rare diseases identified to date. However, if these conditions result from correctable cellular or genetic defects, cell and gene therapies […]
The obesity rate has been steadily climbing and so have scientific efforts to understand why. A new study, published in Nature Communications, takes a closer look at the genes behind body weight and how they […]
A new study shows that preeclamptic and hypertensive pregnant women’s risk of getting cardiovascular disease is linked to their baby’s birthweight.This article was originally published on MedicalXpress.com
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with obstructive sleep apnea (OSA), according to a study presented at CHEST […]
Phthalate exposure is associated with adverse effects on cardiovascular health in patients with chronic kidney disease (CKD), according to a study published online Oct. 14 in Renal Failure.This article was originally published on MedicalXpress.com
Living in a neighborhood where people feel safe and supported is linked to a reduced risk of psychosis among Stockholm residents—but only for people of Swedish or European origin.This article was originally published on MedicalXpress.com
For patients with diabetes and early-stage pulmonary malignancies, administration of a sodium-glucose cotransporter 2 inhibitor (SGLT2-i) slows nodule growth and reduces the need for surgical interventions, according to a study presented at CHEST 2025, the […]
© 2025 SimplyWell.ca